BlackBerry and NantHealth Launch NantOmics Cancer Genome Browser
BlackBerry and NantHealth today announced a secure clinical genome browser that gives doctors access to patients' genetic data on the BlackBerry Passport smartphone - the NantOmics Cancer Genome Browser.
The NantOmics Cancer Genome Browser platform on the BlackBerry Passport enables interactive reporting on genomics data for physicians and other treatment providers in clinical settings - for example, giving oncologists a powerful view into the individual genetic alternations that make each patient' disease unique and
highlighting relevant treatment options.
Powered by BlackBerry' mobile security infrastructure, the NantOmics Cancer Genome Browser is encrypted to allow deployment in a HIPAA-secured environment, enabling clinicians to securely access patient data as soon as it's available, wherever they are.
The NantOmics Cancer Genome Browser will be demonstrated at the Consumer Electronics Show (CES) in January and will be preloaded on BlackBerry Passport devices and available to the professional community in early 2015.
Powered by BlackBerry' mobile security infrastructure, the NantOmics Cancer Genome Browser is encrypted to allow deployment in a HIPAA-secured environment, enabling clinicians to securely access patient data as soon as it's available, wherever they are.
The NantOmics Cancer Genome Browser will be demonstrated at the Consumer Electronics Show (CES) in January and will be preloaded on BlackBerry Passport devices and available to the professional community in early 2015.
